Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 856–870 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3635 RDH5 Gene Fundus Albipunctatus Genetic Test This genetic test identifies mutations in the RDH5 gene associated with Fundus Albipunctatus, an inherited retinal dystrophy.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RDH5 gene sequence", "Pathogenic variants in RDH5"] Parameters [] Preparation [] Indications ["Suspected Fundus Albipunctatus", "Family history of retinal dystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 82455-4 ICD-10: H35.59 Clinical summary This genetic test identifies mutations in the RDH5 gene associated with Fundus Albipunctatus, an inherited retinal dystrophy.
TEST-2765 RET Gene Hirschsprung Disease Genetic Test This test evaluates the RET proto-oncogene for pathogenic variants associated with Hirschsprung disease and Multiple Endocrine Neoplasia type 2.	Whole blood (EDTA or FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RET gene pathogenic variants", "Exon coverage", "Splice-site regions"] Parameters [] Preparation [] Indications ["Suspected Hirschsprung disease", "Family history of Hirschsprung disease or MEN2", "Pre-operative diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21687-8 ICD-10: Q43.1, Z15.01, Z14.8 Clinical summary This test evaluates the RET proto-oncogene for pathogenic variants associated with Hirschsprung disease and Multiple Endocrine Neoplasia type 2.
TEST-1168 Retinal Degeneration Gene Panel Test This test evaluates over 250 genes associated with inherited retinal dystrophies using Next-Generation Sequencing (NGS). It identifies genetic mutations contributing to conditions...	Peripheral whole blood	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic mutations in 250+ genes linked to retinal dystrophies", "Analytical sensitivity"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected hereditary retinal disorder", "Confirmation of clinical diagnosis", "Prognosis determination", "Guidance for gene-specific therapies", "Clinical trial eligibility assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94395-2 ICD-10: H35.5 Clinical summary This test evaluates over 250 genes associated with inherited retinal dystrophies using Next-Generation Sequencing (NGS). It identifies genetic mutations contributing to conditions like retinitis pigmentosa and Stargardt disease.
TEST-3215 Reverse T3 (rT3) Test This diagnostic test evaluates the level of reverse triiodothyronine (rT3), an inactive thyroid hormone isomer, in the blood.	Serum or Plasma	2–3 weeks (send-out test)	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Reverse Triiodothyronine (rT3)", "Peripheral thyroid hormone conversion"] Parameters [{"name": "Reverse T3 (rT3)", "reference_range": null}] Preparation ["No fasting required", "No medication changes required unless instructed by physician", "Complete and sign mandatory Send Out Consent Form (Form 35)"] Indications ["Suspected non-thyroidal illness", "Optimizing thyroid replacement therapy", "Ruling out true hypothyroidism when TSH/free T4 are inconclusive"] Measurement technique Confirm with laboratory Codes LOINC: 30532-3 ICD-10: E07.81 Clinical summary This diagnostic test evaluates the level of reverse triiodothyronine (rT3), an inactive thyroid hormone isomer, in the blood.
TEST-3497 RGS9BP Gene Bradyopsia Genetic Test This test detects pathogenic variants in the RGS9BP gene associated with bradyopsia, a rare cone dysfunction syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RGS9BP gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["Inform phlebotomist if taking blood-thinners.", "Genetic counselling session required before testing."] Indications ["Suspected cone dysfunction", "Distinguishing bradyopsia from other retinal disorders", "Evaluating dynamic vision in athletes", "Research purposes"] Measurement technique Confirm with laboratory Codes LOINC: 94900-7 ICD-10: H53.8 Clinical summary This test detects pathogenic variants in the RGS9BP gene associated with bradyopsia, a rare cone dysfunction syndrome.
TEST-2623 RIN2 Gene Macrocephaly, Alopecia, Cutis Laxa, & Scoliosis Genetic Test This genetic test evaluates the entire coding region of the RIN2 gene for pathogenic variants associated with MACS syndrome.	Whole Blood (EDTA) or DNA FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RIN2 gene", "Full coding region analysis"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counseling session mandatory", "Clinical history form completion required before phlebotomy"] Indications ["Clinical suspicion of MACS syndrome", "Need for definitive molecular diagnosis", "Family counseling and surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 95278-0 ICD-10: Q87.8 Clinical summary This genetic test evaluates the entire coding region of the RIN2 gene for pathogenic variants associated with MACS syndrome.
TEST-2423 RIPK4 Gene (Popliteal Pterygium Syndrome, Lethal Type) Genetic Test This test identifies pathogenic variants in the RIPK4 gene associated with lethal popliteal pterygium syndrome.	Whole Blood (EDTA), FTA Card, or Buccal Swab (Extracted DNA accepted)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation [] Indications ["Suspected lethal popliteal pterygium syndrome", "Family history of popliteal pterygium syndrome", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 48767-8 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the RIPK4 gene associated with lethal popliteal pterygium syndrome.
TEST-3908 RNF128 Gene Autism Genetic Test This test sequences the RNF128 gene to detect pathogenic variants associated with Autism Spectrum Disorder (ASD). It uses Next-Generation Sequencing (NGS) with Sanger confirmation...	Peripheral whole blood (EDTA tube) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic and likely pathogenic variants in the RNF128 gene", "Coding exons and canonical splice sites of the RNF128 gene"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory", "No specific fasting or medication adjustments required for the blood sample"] Indications ["Diagnosis of Autism Spectrum Disorder (ASD)", "Family risk assessment for ASD", "Genetic counselling for individuals with ASD"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: F84.0, Z13.858, Z15.89 Clinical summary This test sequences the RNF128 gene to detect pathogenic variants associated with Autism Spectrum Disorder (ASD). It uses Next-Generation Sequencing (NGS) with Sanger confirmation for high diagnostic sensitivity.
TEST-4028 RNF213 Gene Susceptibility for Moyamoya Disease Type 2 (Genetic Testing) Test This genetic test evaluates the RNF213 gene for pathogenic variants associated with Moyamoya disease type 2.	Whole Blood (EDTA) or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RNF213 gene"] Parameters [] Preparation ["No special preparation required", "Inform phlebotomist of bleeding disorders or anticoagulant use"] Indications ["Family history of Moyamoya disease", "Clinical suspicion of Moyamoya disease", "Risk assessment for Moyamoya disease"] Measurement technique Confirm with laboratory Codes LOINC: 74832-3 ICD-10: I67.5 Clinical summary This genetic test evaluates the RNF213 gene for pathogenic variants associated with Moyamoya disease type 2.
TEST-4504 ROBO3 Gene Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS) Genetic Test This genetic test identifies pathogenic variants in the ROBO3 gene associated with Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ROBO3 gene", "Coverage of ROBO3 coding regions and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected diagnosis of Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS)", "Individuals with clinical features suggestive of HGPPS"] Measurement technique Confirm with laboratory Codes LOINC: 96993-9 ICD-10: H51.8 Clinical summary This genetic test identifies pathogenic variants in the ROBO3 gene associated with Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS).
TEST-3064 ROMA (Risk of Ovarian Malignancy Algorithm) Test The ROMA test evaluates the probability of ovarian malignancy in women with a pelvic mass by combining CA125, HE4, and menopausal status.	Serum or Plasma	Same-day (sample collected Mon/Thu before 4 PM)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum CA125 levels", "Serum HE4 levels", "Menopausal status"] Parameters [{"name": "CA125", "reference_range": null}, {"name": "HE4", "reference_range": null}, {"name": "ROMA Score", "reference_range": null}] Preparation ["Menopausal status must be known", "No specific fasting required"] Indications ["Evaluation of adnexal masses in premenopausal women", "Evaluation of adnexal masses in postmenopausal women", "Risk stratification for epithelial ovarian cancer"] Measurement technique Confirm with laboratory Codes LOINC: 77399-3 ICD-10: R97.6 Clinical summary The ROMA test evaluates the probability of ovarian malignancy in women with a pelvic mass by combining CA125, HE4, and menopausal status.
TEST-4073 RPGRIP1L Gene COACH Syndrome Genetic Test This test provides definitive molecular confirmation of COACH syndrome by identifying pathogenic variants in the RPGRIP1L gene.	Whole blood or dried blood spot (peripheral)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RPGRIP1L gene pathogenic variants"] Parameters [] Preparation ["No fasting required.", "Do not discontinue prescribed medication without consulting your physician.", "Mandatory pre-test genetic counseling is required.", "A signed informed consent document must be completed during counseling."] Indications ["Suspected COACH syndrome", "Genetic counseling", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81403-8 ICD-10: Q04.3 Clinical summary This test provides definitive molecular confirmation of COACH syndrome by identifying pathogenic variants in the RPGRIP1L gene.
TEST-3290 RPL15 Gene Diamond-Blackfan Anemia Type 12 Genetic Test This test identifies pathogenic variants in the RPL15 gene associated with Diamond-Blackfan anemia type 12.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks (Express available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RPL15 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected Diamond-Blackfan anemia", "Family history of Diamond-Blackfan anemia", "Pre-transplant evaluation", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 48000-4 ICD-10: D61.0 Clinical summary This test identifies pathogenic variants in the RPL15 gene associated with Diamond-Blackfan anemia type 12.
TEST-3297 RPS26 Gene Diamond-Blackfan Anemia Type 10 Genetic Test (NGS) This test analyzes the RPS26 gene for mutations associated with Diamond-Blackfan Anemia Type 10.	Peripheral blood (whole blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RPS26 gene sequence", "Single nucleotide variants", "Indels", "Large deletions"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Provide detailed family history", "Attend pre-test genetic counseling session"] Indications ["Suspected Diamond-Blackfan Anemia Type 10", "Family history of Diamond-Blackfan Anemia", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: D61.01 Clinical summary This test analyzes the RPS26 gene for mutations associated with Diamond-Blackfan Anemia Type 10.
TEST-5585 RSPH4A Gene Primary Ciliary Dyskinesia Type 11 Genetic Test This genetic test identifies mutations in the RSPH4A gene associated with primary ciliary dyskinesia type 11.	Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RSPH4A gene mutations", "Copy Number Variations (CNVs) in the RSPH4A gene"] Parameters [] Preparation ["Pre-test genetic counseling is recommended"] Indications ["Suspected primary ciliary dyskinesia type 11", "Family history of PCD", "Diagnostic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 81269-5 ICD-10: Q34.8 Clinical summary This genetic test identifies mutations in the RSPH4A gene associated with primary ciliary dyskinesia type 11.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories